Loading data...
Loading data...
Analyzing the stock…
70
Gathering technical, fundamental, and market data — a few seconds
Finance · ·
$20.80
▲ $0.09 (+0.4%)
Market data updated: 09/22 11:41 AM
Fundamentals updated: 09/22/2026
News analyzed: 09/22/2026
Market Cap
$441.40M
Day Range
$20.57 - $21.05
52-Week Range
$15.80 - $22.46
Beta
—
Next Earnings
15.10.2026
Support
$20.02
Resistance
$22.46
+18.3% (1Y)
Strengths: 7/25 factors positiveRisk: Medium
This score and all analysis on this page are for informational and educational purposes only and do not constitute investment advice. Read the full disclaimer
Weighted: Technical 25% · Fundamental 20% · Growth 15% · Valuation 15% · News 10% · Quality 10% · Risk 5%
Overall Score
🔴 Bearish
Technical Trend
🔴 Bearish
Insiders
🟢 Bullish
Computed directly from the same signals behind the score above — not AI-generated.
Biggest positive driver
Leverage risk
Debt/equity: 0.17
Risk
Biggest negative driver
DCF Fair Value
Estimated fair value: -$7.26 vs. price $20.80 (-134.9%)
Fair Value
What to watch next
When today echoes the past.
NO RELIABLE ECHO FOUND
Only 2 historical analog(s) found after removing overlapping dates — too few for a statistically meaningful comparison.
Historical matches considered: 2
TIME ECHO identifies historical situations that resemble the current market state. Historical outcomes are not guarantees of future performance. Similarity does not imply causation, and results may change as new data becomes available.
🗓️ What Changed This Week
🌱 Building History
We don't have a real data point from a week ago for this stock yet. The weekly comparison will appear once enough history has accumulated.
📊 Score History
42
Today
—
30D
—
90D
—
1Y
🐂🐻 Investment Thesis
🐂 Bull Case
🐻 Bear Case
🔍 What Could Prove This Wrong
This isn't a price-direction forecast — just a synthesis of real, already-computed data, and future conditions that could change the picture.
🧬 STOCK DNA
This stock's profile across 8 real dimensions — a research tool, not a recommendation
Growth
54
Quality
55
Value
38
Momentum
26
Risk
56
Sentiment
20
Fundamental
55
Institutional
100
Stocks with a similar DNA right now
This stock hasn't been analyzed by StockIQAI's movement engine yet — coverage is still expanding. Check back soon.
Recent media coverage of Colony Bankcorp, Inc. (CBAN) has primarily focused on its strong dividend performance, positioning it as a top choice for income-focused investors. Multiple sources highlight its consistent dividend payouts, favorable yield, and momentum in stock price strength, suggesting it remains a reliable option for dividend-focused portfolios. Some articles also mention speculative trading activity, though no major operational or financial shifts are explicitly detailed.
AI summary based on English-language news sources only — not investment advice.
Everyone's writing about Colony Bankcorp, Inc.. News trend score: 20. Reason: 11 of the last 20 articles are negative, versus 6 positive.
News trend analysis is based on article sentiment only, and is not investment advice or financial counsel. Read the full disclaimer
🌡️ Emotional Temperature
28
🎯 Conviction (vs. Emotion)
52
Psychology
34
Fundamentals
55
Technical
26
Valuation
38
A sharp drop, unusual volume, and negative news sentiment all at once — selling pressure that looks emotional.
The price is holding at a real, documented historical support/resistance level (a 50-day high or low).
Price, volume, and sentiment accelerating together — a sign investors are chasing the price, not just following it.
The stock is moving in lockstep with its peers at the same intensity, rather than on its own data.
Extreme momentum, price far above its moving average, and a large premium over fair value.
Price (3M)
-1%
Market Narrative
29
Fundamental Reality
52
Narrative Gap
-23
🧠 StockIQ Psychologist
The dominant herding behavior reflects CBAN’s relative outperformance amid peer weakness, consistent with traders aligning with peer trends rather than independent conviction. The anchoring score suggests traders may be reluctant to push past resistance, while low FOMO and panic scores indicate no extreme emotional urgency. The narrative gap (-13) hints at a disconnect between market perception and fundamentals, leaving open whether herding persists or shifts if CBAN’s relative strength fades. Key uncertainty lies in whether the stock’s slight outperformance remains sustainable or if traders revert to peer averages.
Updated: 09/09/2026, 12:44 AM
What could change this?
👥 What the crowd believes
""Why Colony Bankcorp (CBAN) is a Great Dividend Stock Right Now""
""Bank of South Carolina: Recent Earnings Surge Has Been Noticed By The Market" (related context for CBAN growth)"
""Here's Why Momentum in Colony Bankcorp (CBAN) Should Keep Going""
""Dividend Champion, Contender, And Challenger Highlights" (weekly summaries)"
Signal classification confidence: High (confidence in the behavioral read, not a price prediction). Describes observable market behavior, not what any individual investor thinks, and is not a buy/sell signal.
🏛️ Investor DNA — Historical Investors
A Historical Strategy Simulation: assuming each investor follows their documented principles, how would they rate this stock today? This is not a prediction of what they would actually do.
🟢 Best match
Edgar Lawrence Smith — 100/100
🔴 Weakest match
Philip Fisher — 25/100
🗣️ Why do they disagree?
The stark divide in verdicts for CBAN reflects deep contrasts in methodological priorities. The most bullish signals—from Smith (100) and Bagehot (100)—stem from long-term fundamentals and balance-sheet strength, while Graham’s defensive (87) and enterprising (50) scores highlight a nuanced view: attractive but not a deep bargain. Meanwhile, growth-oriented investors like Lynch (75) and Marks (74) see upside potential, though Marks’ cycle-adjusted score (58) dampens enthusiasm by flagging mid-cycle risks. Fisher’s low score (25) and Nelson’s overbought warning (33) underscore skepticism about speculative appeal or timing, while Livermore’s neutral stance (54) and Schwager’s indecision (45) suggest no clear momentum. The tension between fundamentalists (Smith, Graham) and cyclical/crowd-aware strategists (Nelson, Fisher) reveals whether the stock’s merits lie in enduring value or speculative timing.
Walter Bagehot
Lombard Street (1873)
🟢 100
Not enough balance-sheet data for a real Bagehot read
Key question
Does this company have enough liquidity to survive real stress?
⚠️ Partial data for this stock — score is less reliable — Data availability: 25%
Fact → Principle → Simulation
Edgar Lawrence Smith
Common Stocks as Long-Term Investments (1924)
🟢 100
Looks like a real 'buy and hold for a decade' candidate
Key question
Is this a stock I'd be happy to hold and forget about for a decade?
Fact → Principle → Simulation
Charles Mackay
Extraordinary Popular Delusions and the Madness of Crowds (1841)
🟢 93
No obvious signs of crowd mania
Key question
Am I being swept along with the crowd, or thinking for myself?
Fact → Principle → Simulation
Samuel Armstrong Nelson
The ABC of Stock Speculation (1903)
🟢 93
Cycle position looks favorable — closer to oversold than overbought
Key question
Is the price overextended, or is there still room to move?
Fact → Principle → Simulation
Benjamin Graham
Security Analysis (1934) / The Intelligent Investor (1949)
🟢 89
Attractive to a Defensive Graham Investor
Key question
Where is my margin of safety?
Fact → Principle → Simulation
Peter Lynch
One Up on Wall Street (1989)
🟢 75
Growth candidate — the price hasn't caught up to the growth
Key question
Is the growth worth the price?
Fact → Principle → Simulation
Howard Marks
The Most Important Thing (2011) / Mastering the Market Cycle (2018)
🟢 75
Risk appears reasonably priced — no obvious cycle-timing red flag
Key question
What is the market probably misunderstanding about the risk here?
Fact → Principle → Simulation
Gerald M. Loeb
The Battle for Investment Survival (1935)
🟢 69
Reasonable capital-preservation profile
Key question
How much capital could I lose here if I'm wrong?
Fact → Principle → Simulation
Jack Schwager
Market Wizards (1989)
🟢 69
A real, disciplined setup with favorable reward/risk
Key question
What's the risk/reward here, and where is my exit point?
Fact → Principle → Simulation
Howard Marks (Market Cycle)
Mastering the Market Cycle (2018)
🟢 67
Looks early-to-mid cycle, not overextended
Key question
Where are we in the cycle right now — near a hot extreme, or a cold one?
Fact → Principle → Simulation
Thorstein Veblen
The Theory of Business Enterprise (1904)
🟡 59
Mixed signal on whether growth translates to real profit
Key question
Is management building real value, or just building itself?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Burton Malkiel & John Bogle
A Random Walk Down Wall Street (1973) / The Little Book of Common Sense Investing (2007)
🟡 56
Mixed case — the evidence for picking this stock over an index is not strong
Key question
Do I actually have an edge here, or do I just think I do?
Fact → Principle → Simulation
Morgan Housel
The Psychology of Money (2020)
🟡 53
Moderate — holdable, but not effortless
Key question
Could I live with this volatility long enough for compounding to actually work?
Fact → Principle → Simulation
Benjamin Graham (Enterprising Investor)
The Intelligent Investor (1949) — the Enterprising Investor chapters
🟡 52
Some discount, but not the deep 'net-net' bargain Graham's enterprising bar sets
Key question
Is the stock statistically cheap enough to justify the extra risk?
⚠️ Partial data for this stock — score is less reliable — Data availability: 45%
Fact → Principle → Simulation
Jesse Livermore
Reminiscences of a Stock Operator (1923) / How to Trade in Stocks (1940)
🟡 50
No clear trend — Livermore preferred to stay out of this
Key question
What is the price telling me right now?
Fact → Principle → Simulation
Philip Fisher
Common Stocks and Uncommon Profits (1958)
🔴 25
Doesn't show the quality/growth signature Fisher required
Key question
How exceptional is this business, really?
⚠️ Partial data for this stock — score is less reliable — Data availability: 35%
Fact → Principle → Simulation
Based on the last 282 trading days, calculated from real price data. Click an indicator for details and a chart.
🔴 Most indicators support a downtrend (1 bullish · 8 bearish · 2 neutral)
A market-structure read based purely on real price and volume data — not full classic Wyckoff schematic identification (Phase A-E), but a quantitative analysis of what can reliably be computed: trading ranges, "effort vs. result", volume within the range, and Spring/Upthrust detection.
The stock is in a trading range, but the picture isn't yet clear enough on the likely direction.
Low confidence
$20.02
Range Bottom
$22.46
Range Top
50
Trading Days in Range
The Wyckoff Method, developed by Richard Wyckoff in the early 20th century, reads the balance of supply and demand through price and volume, based on the premise that large investors ("smart money") quietly accumulate shares before rallies and quietly distribute them before declines. The read here is based solely on real price and volume data — full, precise identification of classic Wyckoff patterns (such as Phases A-E) requires human chart-reading experience and judgment, so this is an approximate algorithmic read, not a substitute for professional analysis. This should not be considered investment advice.
Gross Margin
—
Operating Margin
—
Net Margin
16.9%
EBITDA Margin
—
ROE
7.5%
ROA
0.8%
ROIC
—
EPS
$1.59
Cash
$257.64M
Total Debt
$258.10M
Current Ratio
—
Debt/Equity
0.17
אין נתונים היסטוריים זמינים.
Total dividend per share paid each year, over the last 5 years.
| Ex-Dividend Date | Amount per Share |
|---|---|
| 5.8.2026 | $0.120 |
| 6.5.2026 | $0.120 |
| 5.5.2026 | $0.120 |
| 11.2.2026 | $0.120 |
| 10.2.2026 | $0.120 |
| 5.11.2025 | $0.115 |
| 4.11.2025 | $0.115 |
| 6.8.2025 | $0.115 |
| 5.8.2025 | $0.115 |
| 7.5.2025 | $0.115 |
| 6.5.2025 | $0.115 |
| 5.2.2025 | $0.115 |
How is Fair Value calculated? →
Current Price
$20.80
Estimated Fair Value (DCF)
-$7.26
Model estimate — not a price target. Highly sensitive to growth/discount-rate assumptions.
Gap
-134.9%
🔴 Appears expensive relative to estimated value
Year 1 Growth Rate
10.0%
Discount Rate (WACC)
9.0%
Terminal Growth Rate
2.5%
Projection Years
5
| Year | Growth Rate | Projected FCF | Present Value |
|---|---|---|---|
| 1 | 10.0% | $-7.59M | $-6.96M |
| 2 | 8.1% | $-8.21M | $-6.91M |
| 3 | 6.3% | $-8.72M | $-6.73M |
| 4 | 4.4% | $-9.10M | $-6.45M |
| 5 | 2.5% | $-9.33M | $-6.06M |
Base FCF (last actual year)
$-6.90M
Terminal Value
$-147.08M
Present Value of Terminal Value
$-95.59M
Enterprise Value
$-128.70M
Net Debt
$464.00K
Equity Value
$-129.17M
*The DCF model is an estimate based on assumptions — not a guaranteed forecast. You can change the assumptions to examine different scenarios.
Book Value per Share
$17.69
Tangible Book Value per Share (Tangible NAV)
$17.32
Sentiment based on basic keywords (not AI) — 6 positive, 3 neutral, 11 negative out of the last 20 articles.
Yahoo · 21.9.2026
Yahoo · 17.9.2026
Benzinga · 17.9.2026
Yahoo · 4.9.2026
Zacks · 4.9.2026
Zacks · 19.8.2026
Zacks · 19.8.2026
SeekingAlpha · 14.8.2026
Zacks · 14.8.2026
SeekingAlpha · 6.8.2026
Zacks · 3.8.2026
Zacks · 3.8.2026
SeekingAlpha · 31.7.2026
GuruFocus.com · 23.7.2026
MarketBeat · 23.7.2026
Moby · 23.7.2026
SeekingAlpha · 23.7.2026
SeekingAlpha · 23.7.2026
Zacks · 22.7.2026
Associated Press · 22.7.2026
Colony Bankcorp, Inc. (CBAN) currently has a StockIQ AI score of 42/100, rated "Weak". The score is a weighted average across up to 7 categories (technical, fundamental, growth, fair value, news, quality, risk), based on real data only.
CBAN currently scores 42/100 (Weak) across the categories we measure. StockIQ doesn't give buy/sell recommendations — use this as one data point in your own research, not as investment advice.
Per StockIQ's DCF model, CBAN's estimated fair value is -$7.26, which is 134.9% below the current price of $20.80. This is one valuation model among several signals in the fair-value category, not a price target.
CBAN's technical score is 26/100, which currently reads as bearish — based on real price/volume signals (moving averages, RSI, MACD, and more), not a prediction of what happens next.
Based on the real signals StockIQ computed: Debt/equity: 0.17; Price is above the 200-day average; Net margin: 16.9% — strong.
Based on the real signals StockIQ computed: Estimated fair value: -$7.26 vs. price $20.80 (-134.9%); Free cash flow growth: -130.9%; Price is below the 50-day average.
Yes — CBAN has a real recorded dividend payment history on StockIQ. See the Dividends section on this page for the actual per-share amounts and dates.
Real transactions by officers and insiders, as reported to the SEC on Form 4 — 10 purchases and 0 sales out of the last 25 filings.
| Name | Transaction Type | Date | Shares | Change | Price |
|---|---|---|---|---|---|
| Canup Edward G | Open Market Purchase | 26.8.2026 | 41,702 | +1,000 | $21.20 |
| Canup Edward G | Open Market Purchase | 26.8.2026 | 1,000 | +1,000 | $21.20 |
| Canup Edward G | Open Market Purchase | 20.8.2026 | 1,000 | +1,000 | $21.25 |
| Canup Edward G | Open Market Purchase | 19.8.2026 | 1,000 | +1,000 | $21.75 |
| Canup Edward G | Open Market Purchase | 19.8.2026 | 1,000 | +1,000 | $21.50 |
| Canup Edward G | Open Market Purchase | 18.8.2026 | 1,000 | +1,000 | $22.00 |
| Canup Edward G | Open Market Purchase | 30.7.2026 | 1,000 | +1,000 | $21.75 |
| Canup Edward G | Open Market Purchase | 30.7.2026 | 1,000 | +1,000 | $21.85 |
| Canup Edward G | Open Market Purchase | 30.7.2026 | 35,702 | +1,000 | $21.85 |
| Canup Edward G | Open Market Purchase | 30.7.2026 | 36,702 | +1,000 | $21.75 |
| Canup Edward G | Grant/Award from Employer | 1.7.2026 | 3,400 | +3,400 | — |
| Shelnutt Derek | Grant/Award from Employer | 1.7.2026 | 3,088 | +3,088 | — |
| Downing Scott Lowell | Grant/Award from Employer | 1.7.2026 | 990 | +990 | — |
| Reed Matthew D. | Grant/Award from Employer | 1.7.2026 | 990 | +990 | — |
| Fountain T Heath | Grant/Award from Employer | 1.7.2026 | 10,576 | +10,576 | — |
| Joiner Paul E III | Grant/Award from Employer | 1.7.2026 | 990 | +990 | — |
| Schmitt Brian D | Grant/Award from Employer | 1.7.2026 | 990 | +990 | — |
| Massee Mark H | Grant/Award from Employer | 1.7.2026 | 990 | +990 | — |
| Mowry Meagan M. | Grant/Award from Employer | 1.7.2026 | 990 | +990 | — |
| Rentz Daniel | Grant/Award from Employer | 1.7.2026 | 1,916 | +1,916 | — |
| Senn Laurie | Grant/Award from Employer | 1.7.2026 | 2,224 | +2,224 | — |
| Hollingsworth Audrey | Grant/Award from Employer | 1.7.2026 | 990 | +990 | — |
| Copeland R Dallis Jr | Tax Withholding in Shares | 1.7.2026 | 25,272 | -1,500 | $20.49 |
| Bagwell Lee | Tax Withholding in Shares | 1.7.2026 | 19,797 | -761 | $20.49 |
| Bateman Leonard H JR | Tax Withholding in Shares | 1.7.2026 | 13,980 | -881 | $20.49 |
Official FINRA data — the number of shares open in short positions, plus daily short-sale activity.
1,055,425 shares short as of 2026-08-31 · vs. 1,004,284 on 2026-07-31
Official biweekly report (FINRA Rule 4560) — no real higher-frequency data exists for this metric.
53.1% of trading volume this week was short selling, vs. 51.6% the prior week
Based on daily short-sale volume (Reg SHO) — a different metric from the open short interest above: this is daily trading volume, not an open position, so it updates weekly rather than biweekly.
Full breakdown of every data type and its source: Data Sources · Methodology